Lomitapide repurposing for treatment of malignancies: A promising direction

Hua-Tao Wu1,2, Bing-Xuan Wu1,2, Ze-Xuan Fang2,3

  • 1Department of General Surgery, the First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.

Heliyon
|July 11, 2024
PubMed

Insights

Drug repurposing offers a cost-effective strategy for cancer therapy. Lomitapide, initially for hypercholesterolemia, shows potential anti-tumor effects by influencing cancer cell apoptosis, autophagy, and metabolism.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Drug development is lengthy and expensive.
  • Drug repurposing accelerates the availability of treatments.
  • Lomitapide is approved for familial hypercholesterolemia.

Purpose of the Study:

  • To review lomitapide's potential as an anti-cancer agent.
  • To explore lomitapide's anti-tumor mechanisms.
  • To support repurposing lomitapide for cancer treatment.

Main Methods:

  • Systematic literature review.
  • Analysis of lomitapide's effects on cancer cell apoptosis.
  • Investigation of lomitapide's impact on cancer cell autophagy.
  • Examination of lomitapide's role in tumor cell metabolism.

Main Results:

  • Lomitapide demonstrates potential anti-cancer properties.
  • Mechanisms include modulation of apoptosis and autophagy.
  • Lomitapide affects tumor cell metabolism.

Conclusions:

  • Lomitapide exhibits promising anti-tumor functions.
  • Repurposing lomitapide for cancer therapy is feasible.
  • Further clinical investigation is warranted.